数位 PCR 市场 - 全球产业规模、份额、趋势、机会和预测，按类型、组件、应用、最终用户、地区和竞争细分，2020-2030 年预测

2024年全球数位PCR市场规模为8.1456亿美元，预计2030年将达13.7262亿美元，预测期内复合年增长率为9.23%。受分子诊断技术的进步和对精准核酸定量日益增长的需求推动，全球数位PCR (dPCR)市场正在经历大幅增长。数位PCR技术已成为一种检测和定量遗传物质的强大工具，具有高灵敏度和特异性，优于传统PCR技术。它无需标准曲线即可对目标DNA或RNA进行绝对定量，特别适用于肿瘤学、传染病检测和基因研究等应用。癌症和传染病的发生率不断上升，以及对精准诊断工具的需求不断增长，促使数位PCR在临床和研究领域中广泛应用。基于液滴和晶片的dPCR平台等技术创新提高了通量、多重化能力和易用性，进一步推动了市场渗透。尤其是数位PCR能够检测低量突变和罕见基因变异，使其成为个人化医疗和液体活检应用的重要工具。除了医疗保健领域，该技术也正在应用于食品安全、环境监测和法医学等领域。

关键市场驱动因素

传染病和慢性病发生率上升

主要市场挑战

数位PCR仪器和耗材成本高

主要市场趋势

技术和自动化的进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球数位PCR市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（液滴式数位 PCR、晶片式数位 PCR、其他）
  • 依组件（系统、试剂盒和分析、试剂和耗材）
  • 依应用（肿瘤学、传染病、罕见疾病、生殖遗传学、其他）
  • 按最终用户（学术和研究机构、生物技术和製药公司、医院和诊所、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 按组件
  • 按应用
  • 按最终用户
  • 按地区

第六章：北美数位PCR市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲数位PCR市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太数位PCR市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲数位PCR市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲数位PCR市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品发布

第 13 章：竞争格局

• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN NV
• Thermo Fisher Scientific Inc.
• Genetron Holdings Limited
• Naveris, Inc.
• SAGA Diagnostics
• Precigenome LLC

第 14 章：策略建议

第15章调查会社について・免责事项

Global Digital PCR Market was valued at USD 814.56 million in 2024 and is expected to reach USD 1372.62 million by 2030 with a CAGR of 9.23% during the forecast period. The global digital PCR (dPCR) market is witnessing substantial growth, driven by advancements in molecular diagnostics and the growing need for precise nucleic acid quantification. Digital PCR technology has emerged as a powerful tool for detecting and quantifying genetic material with high sensitivity and specificity, offering advantages over traditional PCR techniques. It allows for absolute quantification of target DNA or RNA without the need for standard curves, making it especially useful in applications such as oncology, infectious disease detection, and genetic research. The rising prevalence of cancer and infectious diseases, along with increasing demand for accurate diagnostic tools, is contributing to the widespread adoption of digital PCR across clinical and research settings. Technological innovations, such as droplet-based and chip-based dPCR platforms, have improved throughput, multiplexing capability, and ease of use, further driving market penetration. In particular, the ability of digital PCR to detect low-level mutations and rare genetic variants makes it an essential tool in personalized medicine and liquid biopsy applications. In addition to healthcare, the technology is also being adopted in fields like food safety, environmental monitoring, and forensic science.

Key Market Drivers

Rising Prevalence of Infectious and Chronic Diseases

The rising prevalence of infectious and chronic diseases is a significant driver of growth in the global digital PCR (dPCR) market. Infectious diseases such as COVID-19, influenza, HIV, tuberculosis, and hepatitis continue to challenge healthcare systems worldwide, highlighting the urgent need for highly sensitive, specific, and rapid diagnostic tools. For instance, according to WHO 2024, noncommunicable diseases (NCDs) caused 43 million deaths in 2021, representing 75% of global non-pandemic deaths. Of these, 18 million were premature deaths under age 70, with 82% occurring in low- and middle-income countries. Cardiovascular diseases led NCD fatalities at 19 million, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes-related deaths exceeding 2 million.

Digital PCR has emerged as a valuable technology in this context, capable of detecting minute quantities of viral or bacterial genetic material with remarkable accuracy. Its ability to quantify low-abundance targets makes it ideal for early detection, monitoring viral load, and tracking disease progression, all of which are critical for timely treatment and containment of infectious outbreaks. Beyond infectious diseases, the global burden of chronic conditions such as cancer, cardiovascular diseases, and genetic disorders is also rising steadily. In oncology, for example, dPCR plays a crucial role in the detection of rare mutations, analysis of circulating tumor DNA (ctDNA), and monitoring of minimal residual disease, supporting the move toward personalized medicine and targeted therapies. As these diseases often require long-term monitoring and precision in diagnosis, the demand for robust molecular diagnostic tools like dPCR continues to grow. The increasing incidence of co-morbidities and aging populations globally is driving the need for diagnostic technologies that offer both accuracy and efficiency. Digital PCR provides an edge by enabling absolute quantification without the need for standard curves, making it highly reliable for clinical decision-making. In regions with limited healthcare infrastructure, dPCR's precision can be particularly valuable in overcoming diagnostic challenges.

Key Market Challenges

High cost of digital PCR instruments and consumables

The high cost of digital PCR (dPCR) instruments and consumables is a significant challenge impacting the growth and accessibility of the global digital PCR market. Digital PCR technology involves sophisticated instrumentation that requires advanced engineering, precise microfluidics, and sensitive detection systems, all of which contribute to the elevated price of these platforms compared to traditional PCR methods. For many laboratories, especially smaller research facilities and those in developing regions, the initial capital investment for purchasing dPCR machines can be prohibitively expensive. This high upfront cost limits the widespread adoption of the technology, despite its clear advantages in sensitivity and accuracy. In addition to the instrument cost, consumables such as reagents, chips, or droplets used in digital PCR assays tend to be more expensive than those used in conventional PCR. These consumables are often proprietary and must be purchased from specific manufacturers, which further drives up operational expenses. The recurring cost of consumables can strain the budgets of clinical laboratories and research institutions, particularly when large sample volumes need to be analyzed regularly. This cost barrier also affects the integration of digital PCR into routine clinical diagnostics, as healthcare providers may be reluctant to adopt expensive technologies without clear reimbursement policies or cost-benefit evidence. In resource-limited settings, the affordability of the technology remains a major concern, slowing the adoption of dPCR where it could significantly improve diagnostic accuracy. Addressing these cost challenges through technological innovation aimed at reducing manufacturing expenses, increasing automation, and promoting competitive pricing is crucial for expanding the digital PCR market. Additionally, developing cost-effective consumable solutions and fostering partnerships to improve affordability will help increase accessibility and adoption globally.

Key Market Trends

Advancement in Technology and Automation

Advancements in technology and automation are key drivers transforming the global digital PCR (dPCR) market. Recent innovations have focused on improving the accuracy, speed, and user-friendliness of dPCR platforms, making them more accessible and efficient for a broader range of applications. Automated systems now integrate sample preparation, partitioning, amplification, and data analysis into streamlined workflows, significantly reducing manual intervention and the potential for human error. This automation enhances reproducibility and throughput, addressing the demand for faster turnaround times in clinical and research laboratories. Technological progress has also led to the development of more sensitive and versatile dPCR platforms, including droplet-based and chip-based systems capable of multiplexing-simultaneously detecting multiple targets within a single sample. These improvements enable more comprehensive genetic analysis and reduce costs by maximizing data output per run.

User-friendly software with advanced algorithms now supports more straightforward data interpretation, enabling laboratories with limited bioinformatics expertise to adopt digital PCR more easily. Additionally, miniaturization and portable dPCR devices are emerging, facilitating point-of-care testing and on-site analysis, which expands the technology's applicability beyond centralized labs. Advancements in technology and automation are not only improving the performance and reliability of digital PCR but are also lowering operational barriers, accelerating adoption, and expanding market reach across healthcare and non-healthcare sectors.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Genetron Holdings Limited
• Naveris, Inc.
• SAGA Diagnostics
• Precigenome LLC

Report Scope:

In this report, the Global Digital PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital PCR Market, By Type:

• Droplet Digital PCR
• Chip Based Digital PCR
• Others

Digital PCR Market, By Component:

• Systems
• Kits and Assays
• Reagents and Consumables

Digital PCR Market, By Application:

• Oncology
• Infectious Diseases
• Rare Diseases
• Reproductive Genetics
• Others

Digital PCR Market, By End User:

• Academic and Research Institutions
• Biotechnology & Pharmaceutical Companies
• Hospitals and Clinics
• Others

Digital PCR Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital PCR Market.

Available Customizations:

Global Digital PCR Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital PCR Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Droplet Digital PCR, Chip Based Digital PCR, Others)
  • 5.2.2. By Component (Systems, Kits and Assays, Reagents and Consumables)
  • 5.2.3. By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)
  • 5.2.4. By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Component
  • 5.3.3. By Application
  • 5.3.4. By End User
  • 5.3.5. By Region

6. North America Digital PCR Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Component
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital PCR Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Digital PCR Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Digital PCR Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Digital PCR Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Component
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Digital PCR Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Digital PCR Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Digital PCR Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Digital PCR Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Digital PCR Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Digital PCR Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Component
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Digital PCR Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Digital PCR Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Digital PCR Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Digital PCR Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Digital PCR Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Digital PCR Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Component
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital PCR Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Digital PCR Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Digital PCR Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Digital PCR Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Component
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital PCR Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Digital PCR Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Digital PCR Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Bio-Rad Laboratories, Inc.
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Recent Developments
  • 13.1.6. SWOT Analysis
• 13.2. Fluidigm Corporation
• 13.3. F. Hoffmann-La Roche AG
• 13.4. Merck KGaA
• 13.5. QIAGEN N.V.
• 13.6. Thermo Fisher Scientific Inc.
• 13.7. Genetron Holdings Limited
• 13.8. Naveris, Inc.
• 13.9. SAGA Diagnostics
• 13.10. Precigenome LLC

14. Strategic Recommendations

15. About Us & Disclaimer